| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
13,030,000 |
| Market
Cap: |
48.60(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$3.34 - $22.88 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 634 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Eagle Pharmaceuticals is a pharmaceutical company focused on developing medicines to treat diseases of the central nervous system or metabolic critical care therapeutic areas as well as in oncology. Co.'s products include: Belrapzo® (bendamustine ready-to-dilute (RTD) 500ml solution), Bendeka® (infused bendamustine RTD) and Treakisym® for chronic lymphocytic leukemia and non-hodgkin's lymphoma; Ryanodex® (dantrolene sodium) for malignant hyperthermia; EP-4104 Ryanodex® (dantrolene sodium) for the treatment of organophosphate exposure; PEMFEXY™ (pemetrexed for injection) for lung cancer; and EA-114 (fulvestrant) for breast cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
20,245 |
87,045 |
| Total Sell Value |
$0 |
$0 |
$300,027 |
$1,741,115 |
| Total People Sold |
0 |
0 |
1 |
2 |
| Total Sell Transactions |
0 |
0 |
2 |
7 |
| End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Proquest Associates Iv Llc |
10% Owner |
– – • |
2014-02-18 |
4/A |
A |
$0.00 |
$0 |
I/I |
71,934 |
71,934 |
|
- |
|
| Schreiber Alain |
Director |
– • • |
2014-02-18 |
4 |
A |
$0.00 |
$0 |
I/I |
4,448,591 |
71,934 |
|
- |
|
| Schreiber Alain |
Director |
– • • |
2014-02-18 |
4 |
OE |
$0.00 |
$0 |
I/I |
22,194 |
72,291 |
|
- |
|
| Schreiber Alain |
Director |
– • • |
2014-02-18 |
4 |
A |
$0.00 |
$0 |
I/I |
4,448,591 |
71,934 |
|
- |
|
| Schreiber Alain |
Director |
– • • |
2014-02-18 |
4 |
B |
$15.00 |
$4,999,995 |
I/I |
333,333 |
4,770,828 |
2.25 |
- |
|
| Schreiber Alain |
Director |
– • • |
2014-02-18 |
4 |
B |
$15.00 |
$4,999,995 |
I/I |
333,333 |
4,770,828 |
2.25 |
- |
|
| Moorin Jay |
Director |
– • • |
2014-02-18 |
4 |
OE |
$0.00 |
$0 |
I/I |
22,194 |
72,291 |
|
- |
|
| Moorin Jay |
Director |
– • • |
2014-02-18 |
4 |
A |
$0.00 |
$0 |
I/I |
4,448,591 |
71,934 |
|
- |
|
| Moorin Jay |
Director |
– • • |
2014-02-18 |
4 |
B |
$15.00 |
$4,999,995 |
I/I |
333,333 |
4,770,828 |
2.25 |
- |
|
| Proquest Management Llc |
10% Owner |
– – • |
2014-02-18 |
4 |
OE |
$0.00 |
$0 |
I/I |
22,194 |
72,291 |
|
- |
|
| Proquest Management Llc |
10% Owner |
– – • |
2014-02-18 |
4 |
A |
$0.00 |
$0 |
I/I |
4,448,594 |
72,291 |
|
- |
|
| Proquest Management Llc |
10% Owner |
– – • |
2014-02-18 |
4 |
B |
$15.00 |
$4,999,995 |
I/I |
333,333 |
4,770,828 |
1.5 |
- |
|
| Flaum Sander A |
Director |
– • – |
2014-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
20,039 |
29,399 |
|
- |
|
| Ratoff Steven B |
Director |
– • – |
2014-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
10,014 |
19,374 |
|
- |
|
| Tarriff Scott |
President and CEO |
• • – |
2014-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
763 |
1,669,622 |
|
- |
|
| Tarriff Scott |
President and CEO |
• • – |
2014-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
196,485 |
1,668,859 |
|
- |
|
| Ratoff Steven B |
Director |
– • – |
2014-02-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,360 |
|
- |
|
| Flaum Sander A |
Director |
– • – |
2014-02-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,360 |
|
- |
|
| Proquest Management Llc |
10% Owner |
– – • |
2014-02-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
48,361 |
|
- |
|
| Tarriff Scott |
President and CEOOfficer |
• • – |
2014-02-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,472,374 |
|
- |
|
| Schreiber Alain |
Director |
– • • |
2014-02-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
48,361 |
|
- |
|
| Moorin Jay |
Director |
– • • |
2014-02-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
48,361 |
|
- |
|
222 Records found
|
|
Page 9 of 9 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.27 (6.75%) 
